BiotechTube
Home/TILT Biotherapeutics/Akseli Hemminki
AH

Akseli Hemminki

Founder & CEO

TILT Biotherapeutics

Therapeutic Areas

OncologySolid Tumors

TILT Biotherapeutics Pipeline

DrugIndicationPhase
TILT-123 (igrelimogene litadenorepvec)Solid TumorsPhase 1